SCHEMBL658474

SCHEMBL658474

COC(=O)C(C(=O)OC)C(CC(=O)c1ccc(C(F)(F)F)cc1)c1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.55
UTS2R Q9UKP6 5/20 0.48
CNR2 P34972 1/20 0.45
LDHA P00338 1/20 0.45
LDHB P07195 1/20 0.45
POLB P06746 2/20 0.43
RHOC P08134 1/20 0.43
RHOA P61586 1/20 0.43
PTPN1 P18031 2/20 0.42
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
GSK3B P49841 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
CNR1 P21554 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL658835 0.86 PDPK1 (0.52) PDPK1L3MBTL1UTS2RCNR2POLB
SCHEMBL657567 0.85 PDPK1 (0.78) PDPK1UTS2RCNR2POLBPTPN1
SCHEMBL660915 0.85 L3MBTL1 (0.60) L3MBTL1POLBALDH1A1MAPT
SCHEMBL659208 0.84 L3MBTL1 (0.59) L3MBTL1POLBALDH1A1MAPTGSK3B
SCHEMBL25737214 0.83 PDPK1 (0.79) PDPK1LDHALDHBPTPN1ALDH1A1
SCHEMBL657922 0.82 CYP2C9 (0.61) L3MBTL1CNR2POLBALDH1A1MAPT
SCHEMBL659733 0.80 L3MBTL1 (0.54) L3MBTL1UTS2RCNR2POLBMAPT
SCHEMBL13385520 0.79 POLB (0.52) PDPK1L3MBTL1UTS2RCNR2POLB
SCHEMBL657267 0.78 L3MBTL1 (0.56) PDPK1L3MBTL1POLBALDH1A1MAPT
SCHEMBL23149235 0.77 L3MBTL1 (0.52) L3MBTL1CNR2POLBALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB PDPK1 109/4885L3MBTL1 3302/4885UTS2R 3944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.